“Professor Garai, when is the world’s first cardiac surgery based on STAR stem cell technology intended to begin?”

When a reporter was honored to have a chance to ask questions, he couldn’t wait to ask questions about heart surgery.

"In this regard, we have conducted in-depth consultations with Professor Namura of Tokyo Central Hospital in the Institute of Physical and Technological Research of Sumitomo Pharmaceutical and Diodo University.So far, the right clinical patients have been found.This time, Dr. Naimura will use the heart artery patch cultivated by the Institute of Physical and chemical research of Didu University to treat the aorta bow and the aorta that have become necrotic in patients.In the past, this was an extremely complex and difficult operation, often requiring patients to perform aortic and aortic bow replacement surgeries, and Professor Naimura is the best cardiac surgeon in Japan for such surgery...”

“Because this operation uses a heart artery patch to treat the patient.Therefore, the difficulty of the operation will be greatly reduced.Professor Naimura now only need to paste this heart artery patch on the patient's necrosis ascending aorta and aorta bow parts, the patch of healthy arterial wall cells will automatically repair the damaged cells, so as to achieve the purpose of healing patients, if you want to play a simple metaphor, this technology is actually a bit similar to repair leaky tires..."

“Hahaha...”

With the difference between the operation and explained in an easy-to-understand way on the venue, there was a pleasant laugh in the venue.The reporters who were present also clearly became interested in this magical heart artery patch.You know, as long as people who know some heart disease a little bit will understand that heart muscle tissue is not regenerated cell tissue, once damaged, it can not be repaired, and now, the team led by Professor Jialai Xiu Shu has broken the medical community's problem.The use of regenerative medicine to perform cell-level transplant surgery, so that the original complex surgery becomes simple.And more importantly, this cell-level transplant surgery has more good efficacy and fewer side effects than traditional surgical methods.

When Deyong Shiwei briefly explained the general plan of STAR stem cell intervention for heart surgery, the enthusiasm of the reporters on the scene also increased.Looking at the lectern, I saw that all the reporters on the stage were full of reporters who raised their hands to ask questions.Compared with the scene of the last retinal transplant press conference, this time it is even more enthusiastic.

“The gentleman over there, please...do you have anything to ask?”

"Hi, Professor Galli, there have been rumors that Sumitomo Pharmaceuticals will work with your team to set up a regenerative medical company based on STAR stem cell technology, please... is this rumor true?" 」

Hearing that the reporter actually asked Professor Garai directly, Deyong poetry was naturally not good to answer for the next generation.So the Jialai Show tree opened the microphone in front of him, and then answered the reporter with some seriousness:

“Regarding the establishment of a company, Sumitomo Pharmaceuticals actually mentioned to me a long time ago ... but ... due to the rigorous attitude of the researchers, I have always had difficulty making up my mind.”It was only after the last retinal transplant was declared successful that I realized that perhaps our attitude was a little too conservative.”

"In theory, STAR stem cells can differentiate any tissue in an adult body, which means that once this technology is promoted, any tissues and organs in the human body will have the ability to regenerate."I personally think this technology is very important for us as a country that is already in the population aging.This technology will also revolutionize many treatments in modern medicine.For example, people with diabetes who we think are incurable and can only rely on drugs to maintain health, if one day we use STAR stem cell technology to restore the patient's islet function, will it be possible to fundamentally cure diabetes?

“It’s that to make this a reality as soon as possible, so ... we need more money and talent to invest in STAR stem cell research, and I think we have an obligation to make some of the technologies that are mature enough to be applied to the clinic as soon as possible.”For example, the application of this surgery to the heart artery patch is a very effective alternative to heart surgery.In order for these good technologies to be no longer confined to the lab, I think ... I can accept the use of commercial means to better promote this technology, so as to bring the gospel to more patients, this is what I, a researcher of regenerative medicine, really want to say...”

Hearing Professor Garai's speech so sincerely, there was a round of applause in the venue.Then, many reporters asked about the research on STAR stem cells.As a representative of Sumitomo Pharmaceuticals, Deyong Shiwei also answered some relevant questions one by one.

"Professor Garai, it is said that you have become a strong contender for the Nobel Prize in medicine this year, do you have any expectations for this year's Nobel Prize?"

“This?”I haven’t really thought about it at all, and maybe I’m more accomplished than using STAR stem cell technology to bring health to more patients struggling with disease than the Nobel Prize.”

...

When the press conference was over, Jialai Xiu Shu and Namura, the cardiac surgeon in charge of this clinical trial, also chilled for a while, and then couldn't wait to say goodbye.At this moment, Deyong Shi Weaving suddenly stopped Professor Galai, and then pulled him aside and carefully asked him:

"Professor... have you found a solution to the matter of Ueno Yanjiro, and President Saito has been asking about your progress on your side?"

“Oh... that... I’m still trying to find a solution, but the problems with the immune system are more complicated, so... for a moment and a half, I couldn’t come up with a perfect solution.”However, I believe that as long as the new company is established, I can free up my hands, and then I will definitely think of a safe treatment plan.Yes, what about the patient's immunosuppressant program, the patient's symptoms have not been alleviated!"

"This ... I heard that there is still some effect, but this is only a way to cure the root cause, long after this, Mr. Yan Sanro's body will be indefatigable..."

"Isn't this a very common situation in patients who have had transplants, and in order to extend their lives, there are not a few transplant patients who have been taking immunosuppressants for a long time."So... let’s look at it.”